about
Acaricidal activity of eugenol based compounds against scabies mitesDrug repurposing and human parasitic protozoan diseasesTotal synthesis of thiaplakortone a: derivatives as metabolically stable leads for the treatment of malaria.Antimalarial activity of azadipeptide nitrilesEx vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivaxLysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.Inhibition of chondroitin-4-sulfate-specific adhesion of Plasmodium falciparum-infected erythrocytes by sulfated polysaccharidesComparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitorsDesign and synthesis of screening libraries based on the muurolane natural product scaffold.The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.Inhibition of Plasmodium falciparum growth in vitro and adhesion to chondroitin-4-sulfate by the heparan sulfate mimetic PI-88 and other sulfated oligosaccharides.Plasmodium gametocyte inhibition identified from a natural-product-based fragment library.Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malariaDiscovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stagesSynergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasitesSynthesis and Antiplasmodial Evaluation of Analogues Based on the Tricyclic Core of Thiaplakortones A-D.Potent antimalarial activity of histone deacetylase inhibitor analogues.Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum.Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.HIV and malaria co-infection: interactions and consequences of chemotherapy.Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.HDAC inhibitors in parasitic diseases.Structural basis for binding of Plasmodium falciparum erythrocyte membrane protein 1 to chondroitin sulfate and placental tissue and the influence of protein polymorphisms on binding specificity.Defining the targets of antiparasitic compounds.Synthesis, biological characterisation and structure activity relationships of aromatic bisamidines active against Plasmodium falciparum.Adherence of Plasmodium falciparum infected erythrocytes to CHO-745 cells and inhibition of binding by protein A in the presence of human serum.Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold.Synthesis and evaluation of antimalarial properties of novel 4-aminoquinoline hybrid compounds.Antimalarial activity of pyrroloiminoquinones from the Australian marine sponge Zyzzya sp.Antiretrovirals as antimalarial agents.Antimalarial histone deacetylase inhibitors containing cinnamate or NSAID components.Psammaplysin H, a new antimalarial bromotyrosine alkaloid from a marine sponge of the genus Pseudoceratina.Antiparasitic activity of alkaloids from plant species of Papua New Guinea and Australia.Pestalactams A-C: novel caprolactams from the endophytic fungus Pestalotiopsis sp.Effect of cytokine treatment on the in vitro expression of the P. falciparum adhesion receptor chondroitin-4-sulphate on the surface of human choriocarcinoma (BeWo) cells.Regioselectively modified sulfated cellulose as prospective drug for treatment of malaria tropica.Carrageenans inhibit the in vitro growth of Plasmodium falciparum and cytoadhesion to CD36.Entonalactams A-C: Isoindolinone derivatives from an Australian rainforest fungus belonging to the genus Entonaema.Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors.
P50
Q21136186-D35F8A01-33DD-4896-B251-46ACD6DA1E61Q26999453-E5B3E507-E991-4426-88C9-FF95C889C48AQ33636433-AFA10DCA-A7C9-470E-9446-7BE29CD9DF0BQ33637348-0E616664-3A78-4D5B-873E-6AC2A1525949Q33764147-46BF90CE-BC98-43DF-9344-99AFC657348AQ33798591-33D5AC24-9E80-4676-9C0E-45C7A7FB9B89Q33883564-8C3C8B91-DAEF-4FC9-AD38-89EB3675D944Q34181991-095DAD5C-73CD-4E25-A5F6-083F009D906AQ34197608-F2F8C017-75B8-4446-AE3B-3EF54979C0B2Q34586166-E1728FDD-5EAA-4481-9951-9A66E99C5053Q34973764-3612B27F-55DC-4939-8A53-00930E575982Q35002228-04ADE7DF-C3DE-4E86-BE74-CF4D93BEDA5CQ35073090-FD38D577-C3DA-4179-8041-CECDB5BE28FAQ35182742-9B02B5E8-902C-4BB9-9425-F1849C0D9559Q35636034-BCF503B1-1360-4C26-8C43-7568DA522E25Q35864886-3294F001-EE53-41A8-B88E-EDF9193EC0F2Q36096562-256B8AEE-E23A-4D25-AE92-5237DDE5099CQ36538672-6E6A5C24-6003-42F3-84D4-0A4E91FFD12AQ36744753-0F97730C-99B5-4206-8C57-76E56B3CF54DQ37023155-3876DF67-574A-41C8-900B-59C9DD8FFC7FQ37154523-3E2358C8-29F2-4C67-876A-9DA5DBDE508CQ37626063-984B08EA-658E-42FC-BA69-B24B88DFB179Q37962336-D52D79A9-CED4-482F-9434-F40909D9987FQ38300914-DD476E67-32A5-48DF-8A2C-63A513A6F4A2Q38702544-C0BD74AD-7309-485C-AAC0-112D73601721Q38723552-F06BCDEB-2114-40EC-8510-9EB57F8F3C2FQ38875359-03FA9FD6-3A36-46A2-8663-3CE0CC8C6C59Q38930568-9453E82B-09D0-4361-AA9C-89018496E36CQ39005609-182EECCC-8001-42F4-82EE-E208A288BFE5Q39333451-83CF6FB9-7B7F-46E2-963C-1266553DED93Q39469775-36F23716-69D7-4C4B-B120-8ABE5D343F47Q39588840-49982D68-139F-4667-9CB8-5567EB73B767Q39614696-BF9ADDBA-2333-47FE-81AC-2AA22C1A541EQ39688050-6B667219-EABC-4A59-9888-49FEF22BB22BQ39706658-0DB7A415-0253-469A-B850-B4E7016E8EBCQ40129113-5CE3169B-510A-4B5C-8161-B9BCA0D6FA10Q40206336-3168FA3A-38D2-4205-B3A3-B557614242BBQ40398384-8CFC415A-B0E6-4A62-A966-C9E430E633A5Q40855099-615D92B0-5290-48E7-80C7-ED3B02A4D287Q41838047-C257BC10-5544-427B-9915-853A1CE44C3D
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Kathy Andrews
@ast
Kathy Andrews
@en
Kathy Andrews
@es
Kathy Andrews
@nl
Kathy Andrews
@sl
type
label
Kathy Andrews
@ast
Kathy Andrews
@en
Kathy Andrews
@es
Kathy Andrews
@nl
Kathy Andrews
@sl
prefLabel
Kathy Andrews
@ast
Kathy Andrews
@en
Kathy Andrews
@es
Kathy Andrews
@nl
Kathy Andrews
@sl
P108
P1053
F-9586-2011
P106
P21
P31
P3829
P496
0000-0002-1591-8979